Inactive Instrument

Highlights Allon Therapeutics Inc. Toronto S.E.

Equities

Paladin Labs Inc. completed the acquisition of substantially all assets from Allon Therapeutics, Inc..	13-07-16	CI
Paladin Labs Inc. signed a non-binding term sheet to acquire substantially all assets from Allon Therapeutics, Inc. for CAD 0.9 million.	13-05-30	CI
The United States, New Zealand & Mexico Issue Patent for New Allon Therapeutics, Inc. Platform	12-12-05	CI
Allon Therapeutics, Inc. Completes Patient Treatment in Pivotal Trial Evaluating Allon's Davunetide	12-11-13	CI
Allon Therapeutics, Inc. Receives U.S. Patent for Neurotoxicity Technology Platform in the Treatment of Peripheral Neuropathy	12-03-28	CI
Allon Therapeutics, Inc. Advances Parkinson's Disease Program	12-03-12	CI

No results for this search